Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Advancements in Diagnosis, Treatment for Antiphospholipid Syndrome

Lara C. Pullen, PhD  |  Issue: July 2017  |  July 14, 2017

He also discussed some of the newer immunosuppressive approaches to treatment that focus on complement and mechanistic target of rapamycin (mTOR) pathway inhibition.

He concluded his talk by briefly discussing the 15th International Congress on Antiphospholipid Antibodies, which met in September 2016. He noted that the abstract booklet is free to download.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Free Resource

For more information on APS, download the free iBook, Antiphospholipid Syndrome. A collaborative project of the Hospital for Special Surgery, N.Y., and Nancy-Lorraine University, Nancy, France, Antiphospholipid Syndrome was developed primarily to help medical students better understand the spectrum of aPL-related clinical problems and receive proper education in the diagnosis and management of APS. The authors are Laurent Phialy, Stéphane Zuily and Doruk Erkan.

References

  1. Bertolaccini ML, Amengual O, Andreoli L, et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev. 2014 Sep;13(9):917–930.
  2. Sciascia S, Bertolaccini ML. Thrombotic risk assessment in APS: The Global APS Score (GAPSS). Lupus. 2014;23(12):1286–1287.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:2017 State of the Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)Antiphospholipid Antibody Syndrome (APS)Classification CriteriaDiagnosisHughes SyndromepreventionResearchrheumatologyriskthrombosisTreatment

Related Articles

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    Antiphospholipid Antibody Testing Update

    January 13, 2012

    Successes, challenges, and controversies of diagnostic methods for APS

    Why Antiphospholipid Antibody Syndrome Should Be On Your Radar

    February 1, 2014

    With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch

    Put Hughes Syndrome on Your Radar

    April 1, 2007

    Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences